Safety and Efficacy of Rechallenge With Immune Checkpoint Inhibitors in Advanced Solid Tumor: A Systematic Review and Meta‐Analysis

ABSTRACT Background Immune checkpoint inhibitors (ICIs) have drastically shifted the current landscape toward a wide variety of malignancies. However, ICIs are interrupted owing immune‐related adverse events (irAEs), therapy completion, and disease progression. The risk–benefit of rechallenged ICIs...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Huijun Xu, Yang Yang, Ying Yan, Mengge Li, Shusheng Wu, Lulu Cao, Wenju Chen, Huiqin Luo, Yifu He
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-10-01
coleção:	Cancer Medicine
Assuntos:	immune checkpoint inhibitors immune‐related adverse events rechallenge solid tumor
Acesso em linha:	https://doi.org/10.1002/cam4.70324
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!